
Pluristem Therapeutics
Pluristem Therapeutics Inc. (NasdaqCM: $PSTI, TASE: PSTI/PLTR) is a clinical-stage biotherapy company developing placenta-based cell therapy products.
Employees
Share price
$0.67 PSTI
Authorizing premium user...
Pluristem Therapeutics Inc. (NasdaqCM: $PSTI, TASE: PSTI/PLTR) is a clinical-stage biotherapy company developing placenta-based cell therapy products.